Israel-based Teva pharmaceuticals received U.S. approval to market a generic version of the anti-depressant Prozac. Teva shares rose more than 1 percent on the Tel Aviv Stock Exchange following the company’s announcement.
Keep Jewish Stories in Focus.
JTA has documented Jewish history in real-time for over a century. Keep our journalism strong by joining us in supporting independent, award-winning reporting.
The Archive of the Jewish Telegraphic Agency includes articles published from 1923 to 2008. Archive stories reflect the journalistic standards and practices of the time they were published.
